Canterbury DHB


Stem Cell Transplantation (SCT)

This section was reviewed by Dr Andrew Butler in December 2016. The next review date is December 2018.

In This Section

Introduction, Administration and Quality – SCT

Indications for SCT

Pre-Transplant Patient Assessment

Consents for SCT

Conditioning Schedules for SCT

Infusion of Cellular Therapy Products

Stem Cell Mobilisation

Allogeneic Transplants

Autologous Transplants

Discharge and Follow Up

Complications of SCT

Late Effects Screening after Allogeneic Transplant

Stem Cell Transplants - Information for patients

Reporting Data to International Registries

About this Canterbury DHB document (10203):

Document Owner:

Andrew Butler (see Who's Who)

Last Reviewed:

December 2016

Next Review:

December 2018


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 10203